申请人:Takeda Chemical Industries, Ltd.
公开号:EP0273659A1
公开(公告)日:1988-07-06
Azaspiro compounds of the formula:
wherein R₁ and R₂ independently represent hydrgen, a hydrocarbon residue which may have a substituent, or an acyl group which may have a substituent; R₃ represents hydrogen or a hydrocarbon residue which may have a substituent; each of X₁ and X₂ is oxygen or sulfur; Y represents oxygen, sulfur or a group of the formula: -N(R₄)-, wherein R₄ represents hydrogen or a lower alkyl group; m represents 0 or 1; n represents 0 or 1, and its salt are novel compounds, possess excellent brain functionimproving action, and are of use as drugs for the prevention and therapy of senile dementia of Alzheimer type, vascular-type dementia and dementia derived from Alzheimer's disease, Pick's disease, Huntington's disease, Creutzfeldt-Jakob's disease, Parkinson's disease and spinocerebellar degeneration.
式中的氮杂环化合物:
其中 R₁ 和 R₂ 独立地代表氢、可具有取代基的烃残基或可具有取代基的酰基;R₃ 代表氢或可具有取代基的烃残基;X₁ 和 X₂ 各自为氧或硫;Y 代表氧、硫或式中的基团:-N(R₄)-,其中 R₄ 代表氢或低级烷基;m 代表 0 或 1;n 代表 0 或 1,其盐是新型化合物,具有优异的改善脑功能的作用,可用作预防和治疗阿尔茨海默型老年痴呆症、血管型痴呆症以及由阿尔茨海默病、皮克病、亨廷顿病、克雅氏病、帕金森病和脊髓小脑变性引起的痴呆症的药物。